Hydroxychloroquine, Mainstay Lupus Treatment, Not Associated With Serious Cardiac Complication – Newswise

Newswise — ATLANTA — New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that hydroxychloroquine, an antimalarial drug and mainstay therapy for lupus, does not appear to be associated with QTc…

Click here to view the original article.